We provide you with 20 years of free, institutional-grade data for NSPR stock, allowing you to gain comprehensive visibility into the fundamentals of the company. This in-depth information is essential for making informed investment decisions and understanding the financial health and performance of NSPR. Explore the full financial landscape of NSPR stock.
| Reported Date | CIK | Ticker | Type |
|---|
InspireMD, Inc(NASDAQ:NSPR) 
InspireMD, Inc., a medical device company, focuses on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of vascular and coronary diseases in Europe, Latin America, the Middle East, and Asia. The company offers CGuard carotid embolic prevention ...
Website: http://www.inspiremd.com
Founded: 2005
Full Time Employees: 48
Sector: Healthcare
Industry: Medical Devices
The information provided in this report about NSPR stock is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.